Neehar Parikh
neeharparikh.bsky.social
Neehar Parikh
@neeharparikh.bsky.social
Clinical Director of Hepatology at University of Michigan
Reposted by Neehar Parikh
Celebrating excellence in hepatology! 🌟
We proudly recognized this year’s awardees and honorees at the #TLM25 Awards & Honors Gala. Join us in congratulating this incredible group of 2025 AASLD Distinguished Awardees! 👏👏
November 8, 2025 at 3:00 PM
Reposted by Neehar Parikh
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update

If you take care of patients with #HCC, do not miss this new update from BCLC

#liversky

@easlnews.bsky.social

www.journal-of-hepatology.eu/article/S016....
October 27, 2025 at 5:21 PM
Reposted by Neehar Parikh
What did the largest trial of an early detection of cancer blood test show?
erictopol.substack.com/p/the-larges...
The Largest Study of a Multi-Cancer Early Detection Blood Test
Reviewing the new data and the "liquid biopsy" field
erictopol.substack.com
October 21, 2025 at 1:36 PM
Reposted by Neehar Parikh
Richard Finn presents the results of phase 3 IMbrave152/SkYSCRAPER-14 study at #ESMO25
Anti-TIGIT tiragolumab does not add benefit to atezolizumab-bevacizumab for patients with advanced #HCC
#ESMOAmbassadors @myesmo.bsky.social
October 19, 2025 at 9:09 AM
Reposted by Neehar Parikh
CARES-009 phase 3 study of perioperative camrelizumab and rivoceranib for #HCC
#ESMO25 #ESMOAmbassadors
@myesmo.bsky.social
October 19, 2025 at 9:22 AM
Reposted by Neehar Parikh
Congratulations to AASLD’s newly elected 2026 SIG Steering Committee Leadership! Your enthusiasm, participation, and commitment to shaping AASLD were seen throughout the election process.

Learn more: https://www.aasld.org/2026-aasld-special-interest-group-sig-election-results
October 8, 2025 at 7:55 PM
Reposted by Neehar Parikh
Withdrawing from the War on Cancer: an extraordinarily successful scientific research system that took decades to build, saved millions of lives and generated billions of dollars in profits is being dismantled in short order. @jonathanmahler.bsky.social www.nytimes.com/2025/09/14/m...
Trump Is Shutting Down the War On Cancer
www.nytimes.com
September 14, 2025 at 3:29 PM
Reposted by Neehar Parikh
September 15, 2025 at 3:12 AM
Reposted by Neehar Parikh
We are thrilled to announce the #AASLD 2025 Distinguished Award recipients! Join us in celebrating their achievements and commitment to #hepatology. Learn more about each recipient and their remarkable work: https://bit.ly/4giq0SS
September 12, 2025 at 8:15 PM
Reposted by Neehar Parikh
A very comprehensive review on current state of HCC screening, diagnosis and treatment.

www.jhep-reports.eu/article/S258...

#Liversky

@easlnews.bsky.social
September 8, 2025 at 12:43 PM
Reposted by Neehar Parikh
BREAKING: Gov. JB Pritzker says the Trump administration has sent the Texas National Guard to Great Lakes Naval Base outside Chicago, awaiting orders to deploy to Chicago.
Trump administration officials will target Mexican Independence Day (Sept. 16) celebrations. @wttw.bsky.social
September 2, 2025 at 8:11 PM
Reposted by Neehar Parikh
The @fda.gov just approved @novonordisk.bsky.social #wegovy on an accelerated path for #MASH F2/F3 fibrosis

We now have 2 approved drugs with different MOA and that’s great news for patients. I anticipate at least 5 more approvals in the next 5 years.

#liversky
August 16, 2025 at 7:01 PM
Reposted by Neehar Parikh
🖤 With deep sorrow, we announce the passing of Prof. Dr. Jaime Bosch, President of the Baveno Cooperation.

A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.

Rest in peace, Jaime
July 16, 2025 at 7:11 AM
Reposted by Neehar Parikh
THIS IS HUGE! TWO Phase I HIV vaccine clinical trials have demonstrated that a stepwise mRNA-based vaccination strategy can SUCCESSFULLY activate AND advance immune responses toward producing broadly neutralizing antibodies (bnAbs), a CRITICAL milestone in HIV prevention. Let’s talk about that! 🧪🧵⬇️
May 16, 2025 at 4:00 PM
Reposted by Neehar Parikh
We've greatly underestimated the role of the gut microbiome in fatty liver disease (MASLD). This open-access outstanding review @jclinical-invest.bsky.social is illuminating
www.jci.org/articles/vie...
April 6, 2025 at 4:50 PM
Reposted by Neehar Parikh
📣UM Liver Cancer Diagnosis and Treatment CME Course on March 15th 2025 in Southfield, MI: in person and online. Featuring UM faculty and Dr. Laura Kulik from Northwestern University.

Registration here:

umich.cloud-cme.com/course/cours...
February 14, 2025 at 1:35 AM
Reposted by Neehar Parikh
🔥Nivolumab and Ipilimuma approved by EMA for advanced hepatocellular carcinoma 🔥
👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm
👉great news for our patients > more options in 1st line
😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA
@myESMO @EASLedu @ILCAnews #livertwitter
March 4, 2025 at 3:45 PM
Reposted by Neehar Parikh
How do we interpret and act on disparities in liver cancer outcomes ??

Expert editorial by @laurennephewmd.bsky.social

journals.lww.com/hepcomm/full...

#liversky
1/
Learn, adapt, act: A pragmatic approach for intervening on... : Hepatology Communications
An abstract is unavailable.
journals.lww.com
March 1, 2025 at 1:08 PM
Reposted by Neehar Parikh
The sickest patients are supposed to get priority for lifesaving transplants. But nearly 20% of the time, the American organ transplant system is skipping over hundreds or even thousands of people when it distributes kidneys, livers, lungs and hearts, a New York Times investigation found.
Organ Transplant System ‘in Chaos’ as Waiting Lists Are Ignored
The sickest patients are supposed to get priority for lifesaving transplants. But more and more, they are being skipped over.
www.nytimes.com
February 27, 2025 at 5:54 PM
Reposted by Neehar Parikh
Every year I feel so fortunate to be part of this #LiverCancer community with these amazing friends who are true leaders sharing a common goal!! Amongst the beautiful chaos that is life, it’s important to find your passion and your people 💚. That’s a wrap @hcclive.bsky.social
February 22, 2025 at 11:09 PM
Very sad news regarding Josh Levitsky. He was a seminal mentor for me and a great friend. He will be missed. Much love to his family and the Northwestern Transplant family.
It is with great sadness that we share the passing of our colleague and friend, Dr. Josh Levitsky. Josh served the AST in many roles throughout his career, most recently as Immediate Past President.

We welcome you to share your memories and tributes to Josh here: bit.ly/412SOrs
February 21, 2025 at 5:48 PM
Reposted by Neehar Parikh
Routine [18F]FCH and [18F]FDG PET-CT for tumour staging in all patients with a 1st diagnosis of hepatocellular carcinoma has limited clinical value

Guidelines should continue to emphasise morphological imaging (eg MRI & CT) for staging

#OncSky #MedSky @oncoalert.bsky.social @naultjc.bsky.social
New research - Nault et al - [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study

https://buff.ly/419ebHP

#MedSky #OncSky #LiverSky @naultjc.bsky.social
February 21, 2025 at 7:03 AM
Reposted by Neehar Parikh
This trial by @bloompringle.bsky.social will be seen as one of the most important in the field of FMT - 💩 transplant - for #cirrhosis

Does the 💩 engraft?
Does the 💩 work (improved barrier function)?

This is why PPB is the future

journals.lww.com/hepcomm/full...

#liversky
Safety and efficacy of a defined bacterial consortium,... : Hepatology Communications
thods: We performed a single-center, randomized, placebo-controlled trial of VE303 in adult patients with a history of overt HE (NCT04899115). Eligible patients were taking lactulose and rifaximin, ...
journals.lww.com
February 20, 2025 at 1:16 AM
Reposted by Neehar Parikh
Great review of hemangiomas, FNH, & more by @renumathyd.bsky.social! I encourage all learners to read the classic imaging features.

✅️Review the imaging yourself
✅️Follow up if >5cm
✅️Biopsy for atypical appearance

journals.lww.com/hepcomm/fullte…

@jhepatology.bsky.soci
a#Liverskyk#GITwitterer
https://journals.lww.com/hepcomm/fullte…
February 11, 2025 at 1:39 AM